NZ219255A - Unsaturated amino acids and pharmaceutical compositions - Google Patents
Unsaturated amino acids and pharmaceutical compositionsInfo
- Publication number
- NZ219255A NZ219255A NZ219255A NZ21925587A NZ219255A NZ 219255 A NZ219255 A NZ 219255A NZ 219255 A NZ219255 A NZ 219255A NZ 21925587 A NZ21925587 A NZ 21925587A NZ 219255 A NZ219255 A NZ 219255A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alkyl
- amino
- hydroxy
- phosphono
- amino acids
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- BDYHNCZIGYIOGJ-DUXPYHPUSA-N (e)-2-amino-4-methyl-5-phosphonopent-3-enoic acid Chemical compound OP(=O)(O)CC(/C)=C/C(N)C(O)=O BDYHNCZIGYIOGJ-DUXPYHPUSA-N 0.000 abstract 1
- TUMOUMLCWZEIRK-OWOJBTEDSA-N (e)-2-amino-5-phosphonopent-3-enoic acid Chemical compound OC(=O)C(N)\C=C\CP(O)(O)=O TUMOUMLCWZEIRK-OWOJBTEDSA-N 0.000 abstract 1
- OKDOWCKDTWNRCB-GQCTYLIASA-N [(e)-4-amino-5-ethoxy-2-methyl-5-oxopent-2-enyl]phosphonic acid Chemical compound CCOC(=O)C(N)\C=C(/C)CP(O)(O)=O OKDOWCKDTWNRCB-GQCTYLIASA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3826—Acyclic unsaturated acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/302—Acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/32—Esters thereof
- C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/3217—Esters of acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
Abstract
Phosphorus-contg. unsaturated amino acids of formula (I) and their salts are new: R1 = hydroxy or etherified hydroxy; R2 = H, alkyl, hydroxy or etherified hydroxy; R3 = H, alkyl, haloalkyl, hydroxyalkyl, lower alkoxyalkyl, arylalkyl, lower alkenyl, halogen or aryl; R4 = H, alkyl or arl; R5 = H or alkyl; R6 = carboxy or esterified or amidated carboxy; R7 0 amino opt. substd. by alkyl or aryl; A = opt. alkyl-substd. 1-3C alpha, omega-alkylene or a direct bond; B = methyleue or direct bond; provided that A and B are both direct bonds. Specifically claimed are 9 cpds. including E-2-amino-5- phosphono-3-pentenoic acid, E-2-amino-4-methyl-5-phosphono -3-pentenoic acid, and E-2-amino-4-methyl -5-phosphono-3-pentenoic acid ethyl ester.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH57886 | 1986-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ219255A true NZ219255A (en) | 1989-08-29 |
Family
ID=4190244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ219255A NZ219255A (en) | 1986-02-13 | 1987-02-12 | Unsaturated amino acids and pharmaceutical compositions |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0233154B1 (en) |
| JP (2) | JPH0717665B2 (en) |
| KR (1) | KR900003533B1 (en) |
| AT (1) | ATE70535T1 (en) |
| AU (1) | AU610493B2 (en) |
| CA (1) | CA1331625C (en) |
| CY (1) | CY1821A (en) |
| DD (1) | DD263775A5 (en) |
| DE (1) | DE3775229D1 (en) |
| DK (1) | DK169341B1 (en) |
| ES (1) | ES2038690T3 (en) |
| FI (1) | FI85144C (en) |
| GR (1) | GR3003526T3 (en) |
| HK (1) | HK95594A (en) |
| HU (1) | HU204532B (en) |
| IE (1) | IE59417B1 (en) |
| IL (1) | IL81543A0 (en) |
| NO (1) | NO170938C (en) |
| NZ (1) | NZ219255A (en) |
| PH (1) | PH23762A (en) |
| PT (1) | PT84270B (en) |
| SG (1) | SG92294G (en) |
| ZA (1) | ZA871022B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5175344A (en) * | 1986-02-13 | 1992-12-29 | Ciba-Geigy Corporation | Unsaturated amino acids |
| PT85874B (en) * | 1986-10-09 | 1990-07-31 | Ciba Geigy Ag | PROCESS FOR THE PREPARATION OF OLIGO-PEPTIDES WITH ANTIBIOTIC ACTION |
| PH27591A (en) * | 1987-08-04 | 1993-08-31 | Ciba Geigy Ag | A process for the manufacture of novel unsaturated amino acid compound |
| US5175153A (en) * | 1987-11-30 | 1992-12-29 | Warner-Lambert Company | Substituted alpha-amino acids having pharmaceutical activity |
| US5179085A (en) * | 1989-03-15 | 1993-01-12 | Warner-Lambert Company | N-substituted α-amino acids and derivatives thereof having pharmaceutical activity |
| EP0391850B1 (en) * | 1989-04-07 | 1994-09-28 | Ciba-Geigy Ag | Unsaturated amino-dicarboxylic acid derivatives |
| US5500419A (en) * | 1989-09-19 | 1996-03-19 | Merrell Dow Pharmaceuticals Inc. | NMDA antagonists |
| DK0420806T3 (en) * | 1989-09-26 | 1995-10-16 | Ciba Geigy Ag | Phosphonic acids, processes for their preparation and their use as a drug |
| US5294734A (en) * | 1989-09-26 | 1994-03-15 | Ciba-Geigy Corp. | 4-substituted 2-aminoalk-3-enoic acids |
| US5488140A (en) * | 1989-09-26 | 1996-01-30 | Ciba-Geigy Corporation | 4-substituted 2-aminoalk-3-enoic |
| US5238958A (en) * | 1990-02-26 | 1993-08-24 | Warner-Lambert Company | Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals |
| JPH07505908A (en) * | 1992-09-28 | 1995-06-29 | マックセチーニ、マリア ルイザ | Allosteric modulator of NMDA receptor |
| US20090170813A1 (en) * | 2005-10-18 | 2009-07-02 | Francine Acher | Hypophosphorous Acid Derivatives and their Therapeutical Applications |
| DE102007032669A1 (en) * | 2007-07-13 | 2009-01-15 | Clariant International Limited | Alkylphosphonous acids, salts and esters, process for their preparation and their use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5387314A (en) * | 1977-01-07 | 1978-08-01 | Heiichi Sakai | Nn14099substance |
| GB2104079B (en) * | 1981-08-14 | 1985-08-21 | London Polytech | New aminoacid isomers, their production and their medicinal use |
| US4477391A (en) * | 1981-08-14 | 1984-10-16 | Collins James F | Amino acid isomers, their production and their medicinal use |
-
1987
- 1987-02-10 AT AT87810080T patent/ATE70535T1/en not_active IP Right Cessation
- 1987-02-10 DE DE8787810080T patent/DE3775229D1/en not_active Expired - Lifetime
- 1987-02-10 ES ES198787810080T patent/ES2038690T3/en not_active Expired - Lifetime
- 1987-02-10 EP EP87810080A patent/EP0233154B1/en not_active Expired - Lifetime
- 1987-02-11 DD DD87299843A patent/DD263775A5/en not_active IP Right Cessation
- 1987-02-11 KR KR1019870001107A patent/KR900003533B1/en not_active IP Right Cessation
- 1987-02-11 CA CA000529448A patent/CA1331625C/en not_active Expired - Fee Related
- 1987-02-11 IL IL81543A patent/IL81543A0/en not_active IP Right Cessation
- 1987-02-11 PT PT84270A patent/PT84270B/en not_active IP Right Cessation
- 1987-02-11 FI FI870558A patent/FI85144C/en not_active IP Right Cessation
- 1987-02-12 IE IE36587A patent/IE59417B1/en not_active IP Right Cessation
- 1987-02-12 HU HU87554A patent/HU204532B/en not_active IP Right Cessation
- 1987-02-12 JP JP62028375A patent/JPH0717665B2/en not_active Expired - Lifetime
- 1987-02-12 NZ NZ219255A patent/NZ219255A/en unknown
- 1987-02-12 DK DK070787A patent/DK169341B1/en not_active IP Right Cessation
- 1987-02-12 AU AU68726/87A patent/AU610493B2/en not_active Ceased
- 1987-02-12 ZA ZA871022A patent/ZA871022B/en unknown
- 1987-02-13 PH PH34860A patent/PH23762A/en unknown
- 1987-02-13 NO NO870577A patent/NO170938C/en unknown
-
1992
- 1992-01-08 GR GR910402040T patent/GR3003526T3/el unknown
-
1994
- 1994-07-11 SG SG92294A patent/SG92294G/en unknown
- 1994-09-01 JP JP6208837A patent/JP2509465B2/en not_active Expired - Lifetime
- 1994-09-08 HK HK95594A patent/HK95594A/en not_active IP Right Cessation
-
1995
- 1995-10-20 CY CY182195A patent/CY1821A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ219255A (en) | Unsaturated amino acids and pharmaceutical compositions | |
| EE03999B1 (en) | Use of fumaric acid derivatives | |
| ES2057126T3 (en) | TREATMENT METHOD OF CAQUEXIA AND SOME NEW COMPOUNDS TO USE IN THIS METHOD. | |
| ES2058173T3 (en) | DIOXIALQUILENARIL-DIHIDROPIRIDINAS, INTERMEDIATE PRODUCTS FOR ITS MANUFACTURE, PROCEDURES FOR ITS MANUFACTURE AND ITS USE. | |
| FI853254A0 (en) | FOERFARANDE FOER FRAMSTAELLNING AV NYA STEROIDER, VILKA AER SUBSTITUERADE I 10-STAELLNINGEN MED EN RADIKAL INNEHAOLLANDE EN DUBBEL- ELLER TREDUBBELBINDNING. | |
| BG97123A (en) | DERIVATIVES OF HUMAN BILE SALTS, LIPASE AND PHARMACEUTICAL COMPOSITIONS BASED THEREOF | |
| ZA873721B (en) | Substituted 6-hydroxymethyl-carbapenem antibiotics,a process for the preparation thereof,and the use thereof | |
| ATE32715T1 (en) | PROCESS FOR THE PREPARATION OF B-((2METHYLPROPOXY)-METHYL>-N-PHENYL-N-(PHENYLMETHYL - 1-PYRROLIDINETHANAMINE. | |
| GB1369577A (en) | Indole-carboxylic acid derivatives | |
| FI870057A0 (en) | NYA TYRONINDERIVAT. | |
| DE3882956D1 (en) | AGAINST CONNECTIONS EFFECTIVE AGAINST CEREBRAL INSUFFICIENCY. | |
| HUP0000414A2 (en) | New pentaerythritol derivatives,their production and use and intermediates for their synthesis | |
| ES476031A1 (en) | Maleic acid halfamides having blood pressure raising activity |